Dec 16, 2022 | Featured, Medicare
Patients Rising Now joined 50 other organizations in a letter to President Biden requesting that he direct HHS Secretary Becerra to reopen the National Coverage Determination (NCD) on PET scans for patients participating in Alzheimer’s treatments trials. CMS’ current...
Read more
Dec 15, 2022 | Featured, Medicare
Patients Rising Now joined 17 other patient groups in sending a letter to Congressional Leadership on the impending cuts to Medicare home health services. The letter we sent was an updated version of a letter from September urging passage of the Preserving Access to...
Read more
Oct 31, 2022 | Featured, Medicare, Uncategorized
Patients Rising Now signed onto a letter of support for the bipartisan and bicameral Preserving Patient Access to Home Infusion Act (S.2652/H.R.5067). For decades, home infusion therapy services have been a lifeline for millions of Americans by delivering lifesaving...
Read more
Feb 7, 2022 | Letters Submitted
We have serious concerns about CMS’s draft national coverage determination (NCD) – issued January 11, 2022 – to limit Medicare coverage for monoclonal antibodies directed against amyloid for the treatment of Alzheimer’s Disease (AD) to patients enrolled in...
Read more
